The global market for Parenteral Nutrition was valued at US$7.9 Billion in 2024 and is projected to reach US$11.8 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Parenteral Nutrition market.
The technology and practice of PN have evolved to address both short-term and long-term nutritional needs. Short-term PN is often used to supplement a patient's diet when oral intake is insufficient but still possible, providing partial nutritional support. In contrast, Total Parenteral Nutrition (TPN) serves as the sole source of nutrients for patients who cannot obtain nutrition via the gastrointestinal tract, offering complete nutritional support through intravenous delivery. There are different types of PN based on the method and duration of delivery, including Central Parenteral Nutrition, which delivers nutrients through a large central vein, and Peripheral Parenteral Nutrition, administered through smaller veins and suitable for short-term or partial nutrition. Despite its life-sustaining benefits, PN comes with potential risks such as catheter-related issues, nutrient imbalances, liver dysfunction, and metabolic disturbances, which require careful management and monitoring by healthcare professionals.
The growth of PN, particularly Home Parenteral Nutrition (HPN), is driven by several key factors. Innovations in infusion pumps and catheter designs have made PN more user-friendly and safer, encouraging broader adoption. The shift towards home care settings, driven by the need to reduce hospital stays and healthcare costs, has expanded the application of PN outside traditional hospital environments. PN's integration into palliative care enhances the quality of life for patients with severe illnesses who cannot meet their nutritional needs through oral intake alone. Additionally, the aging population, which often faces swallowing difficulties or digestive issues, increases the demand for PN. Increased patient advocacy and awareness, supportive regulatory policies, and expanded insurance and reimbursement coverage also drive the growth and adoption of PN. These factors collectively reflect changes in healthcare systems, technological advancements, and patient preferences, indicating a continued evolution and expansion of PN across various healthcare settings.
Segments: Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Vitamins & Minerals); Consumer Type (Adults, Children & Newborns); End-Use (Hospitals, Home Care, Clinics, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Parenteral Nutrition Market - Key Trends and Drivers Summarized
Parenteral nutrition (PN) is a critical method in medical nutrition therapy where nutrients are supplied directly into the bloodstream, bypassing the gastrointestinal tract. This advanced feeding technique is essential for individuals whose nutritional needs cannot be met through traditional oral or enteral routes due to various health conditions. PN involves administering a mixture of carbohydrates, lipids, vitamins, amino acids, electrolytes, water, and trace elements through a catheter inserted into a vein. This method can be tailored to meet either complete or supplemental nutritional needs, depending on the patient's specific health situation. PN is typically considered when enteral routes are inadequate or inappropriate due to conditions like bowel obstructions, severe intestinal failure, high output fistulas, or recurrent vomiting.The technology and practice of PN have evolved to address both short-term and long-term nutritional needs. Short-term PN is often used to supplement a patient's diet when oral intake is insufficient but still possible, providing partial nutritional support. In contrast, Total Parenteral Nutrition (TPN) serves as the sole source of nutrients for patients who cannot obtain nutrition via the gastrointestinal tract, offering complete nutritional support through intravenous delivery. There are different types of PN based on the method and duration of delivery, including Central Parenteral Nutrition, which delivers nutrients through a large central vein, and Peripheral Parenteral Nutrition, administered through smaller veins and suitable for short-term or partial nutrition. Despite its life-sustaining benefits, PN comes with potential risks such as catheter-related issues, nutrient imbalances, liver dysfunction, and metabolic disturbances, which require careful management and monitoring by healthcare professionals.
The growth of PN, particularly Home Parenteral Nutrition (HPN), is driven by several key factors. Innovations in infusion pumps and catheter designs have made PN more user-friendly and safer, encouraging broader adoption. The shift towards home care settings, driven by the need to reduce hospital stays and healthcare costs, has expanded the application of PN outside traditional hospital environments. PN's integration into palliative care enhances the quality of life for patients with severe illnesses who cannot meet their nutritional needs through oral intake alone. Additionally, the aging population, which often faces swallowing difficulties or digestive issues, increases the demand for PN. Increased patient advocacy and awareness, supportive regulatory policies, and expanded insurance and reimbursement coverage also drive the growth and adoption of PN. These factors collectively reflect changes in healthcare systems, technological advancements, and patient preferences, indicating a continued evolution and expansion of PN across various healthcare settings.
Report Scope
The report analyzes the Parenteral Nutrition market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Vitamins & Minerals); Consumer Type (Adults, Children & Newborns); End-Use (Hospitals, Home Care, Clinics, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Single Dose Amino Acid Solution segment, which is expected to reach US$4.1 Billion by 2030 with a CAGR of a 7.1%. The Parenteral Lipid Emulsion segment is also set to grow at 7.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $2.0 Billion in 2024, and China, forecasted to grow at an impressive 10.5% CAGR to reach $2.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Parenteral Nutrition Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Parenteral Nutrition Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Parenteral Nutrition Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., Fresenius KABI AG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 36 companies featured in this Parenteral Nutrition market report include:
- Allergan plc
- Amanta Healthcare Ltd
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius KABI AG
- Grifols International S.A.
- ICU Medical Inc.
- Otsuka Pharmaceutical Factory Inc.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Sino-Swed Pharmaceutical Corp. Ltd.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan plc
- Amanta Healthcare Ltd
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius KABI AG
- Grifols International S.A.
- ICU Medical Inc.
- Otsuka Pharmaceutical Factory Inc.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Sino-Swed Pharmaceutical Corp. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 272 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.9 Billion |
| Forecasted Market Value ( USD | $ 11.8 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
